imiquimod has been researched along with adenine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, H; Hirota, K; Isobe, Y; Kawakami, H; Kurimoto, A; Ogino, T; Ogita, H; Sajiki, H; Takaku, H; Tobe, M | 1 |
| Hirota, K; Ichii, S; Isobe, Y; Kawakami, H; Kurimoto, A; Ogino, T; Ogita, H; Sajiki, H; Takaku, H; Tobe, M | 2 |
| Cornella-Taracido, I; De Gregorio, E; Galli-Stampino, L; Harrington, E; Isome, Y; Jain, R; Mbow, ML; Nuti, S; Russo, C; Sammicheli, C; Soldaini, E; Tallarico, J; Tavarini, S; Valiante, NM | 1 |
| Chang, SH; Chen, YJ; Chung, KC; Hsieh, CW; Huang, SW; Kao, JK; Shieh, JJ; Wang, ST; Wu, CY | 1 |
| He, SJ; Li, H; Lin, ZM; Liu, YT; Ma, M; Qi, Q; Shen, YF; Tang, W; Yan, YX; Yang, XQ; Zhu, FH; Zuo, JP | 1 |
| Falke, J; Hulsbergen-van de Kaa, CA; Maj, R; Oosterwijk, E; Witjes, JA | 1 |
| Ahmad, SF; Al-Harbi, MM; Al-Harbi, NO; Alanazi, WA; Alasmari, AF; Alasmari, F; Attia, SM; Bakheet, SA; El-Sherbeeny, AM; Ibrahim, KE; Nadeem, A | 1 |
| Ahmad, SF; Al-Harbi, MM; Al-Harbi, NO; Alotaibi, MR; Alqahtani, F; Alzahrani, KS; Attia, SM; Bakheet, SA; El-Sherbeeny, AM; Ibrahim, KE; Mahmood, HM; Nadeem, A | 1 |
| Chen, D; Chen, G; Lin, J; Lin, Y; Liu, A; Luo, T; Ouyang, D; Pan, H; Qin, M; Zhou, X | 1 |
10 other study(ies) available for imiquimod and adenine
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 2-substituted-8-hydroxyadenine derivatives as orally available interferon inducers without emetic side effects.
Topics: Adenine; Administration, Oral; Aminoquinolines; Animals; Imiquimod; Interferon Inducers; Mice; Mice, Inbred BALB C; Spleen; Structure-Activity Relationship; Vomiting | 2003 |
Synthesis and structure-activity relationships of 2-amino-8-hydroxyadenines as orally active interferon inducing agents.
Topics: Adenine; Administration, Oral; Aminoquinolines; Animals; Imiquimod; Interferon Inducers; Interferons; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Molecular Structure; Spleen; Structure-Activity Relationship | 2003 |
Synthesis and evaluation of 2-substituted 8-hydroxyadenines as potent interferon inducers with improved oral bioavailabilities.
Topics: Adenine; Administration, Oral; Aminoquinolines; Animals; Biological Availability; Cells, Cultured; Dose-Response Relationship, Drug; Hepatitis C; Imiquimod; Interferons; Mice; Rats; Structure-Activity Relationship | 2004 |
Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cells.
Topics: Adenine; Aminoquinolines; Antineoplastic Agents; Cells, Cultured; Dendritic Cells; Enzyme Inhibitors; Fluorescent Antibody Technique; Fluorescent Dyes; Genes, MHC Class II; Humans; Imidazoles; Imiquimod; Macrolides; Proton-Translocating ATPases; Quinolines; Toll-Like Receptor 7 | 2011 |
Imiquimod-induced autophagy is regulated by ER stress-mediated PKR activation in cancer cells.
Topics: Adenine; Aminoquinolines; Apoptosis; Autophagy; Cell Line, Tumor; eIF-2 Kinase; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Endoribonucleases; Fluorescent Antibody Technique; Heat-Shock Proteins; Humans; Imiquimod; Indoles; Microtubule-Associated Proteins; Protein Serine-Threonine Kinases; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Sequestosome-1 Protein; Toll-Like Receptor 7 | 2017 |
Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17.
Topics: Adenine; Adenosylhomocysteinase; Administration, Topical; Animals; Anti-Inflammatory Agents; Butyrates; Cells, Cultured; Cytokines; Female; Humans; Imiquimod; Keratinocytes; Mice, Inbred BALB C; Psoriasis; T-Lymphocytes | 2018 |
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model.
Topics: Adenine; Adjuvants, Immunologic; Administration, Intravesical; Animals; Carcinoma, Transitional Cell; Cell Line, Tumor; Disease Models, Animal; Glycerophospholipids; Imiquimod; Immunologic Factors; Rats; Rats, Inbred F344; Toll-Like Receptor 7; Urinary Bladder; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Dendritic Cells; Disease Models, Animal; Humans; Imiquimod; Immunity, Innate; Interleukin-17; Interleukin-23; Intraepithelial Lymphocytes; Male; Mice; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrazoles; Pyrimidines; Signal Transduction; Skin | 2020 |
Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells.
Topics: Adenine; Animals; BALB 3T3 Cells; Dendritic Cells; Down-Regulation; Imiquimod; Inflammation Mediators; Male; Mice; Neutrophils; Oxidation-Reduction; Oxidative Stress; Peroxidase; Piperidines; Psoriasis; Signal Transduction; Skin | 2020 |
Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation.
Topics: Adenine; Adenosine Triphosphate; Anti-Inflammatory Agents; Antioxidants; Arthritis, Gouty; Caspase 1; Humans; Hydrolyzable Tannins; Imiquimod; Inflammasomes; Inflammation; Interleukin-1beta; Lactate Dehydrogenases; Lipopolysaccharides; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleosides; Propidium; Pyroptosis; Reactive Oxygen Species; Uric Acid | 2022 |